Cargando…

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone

The leading cause of adult injury death in the USA is drug overdose, the majority of which involves prescription opioid medications. Outside of the USA, deaths by drug overdose are also on the rise, and overdose is a leading cause of death for drug users. Reducing overdose risk while maintaining acc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Traci C., Dauria, Emily F, Bratberg, Jeffrey, Davis, Corey S., Walley, Alexander Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527253/ https://www.ncbi.nlm.nih.gov/pubmed/26245865 http://dx.doi.org/10.1186/s12954-015-0058-x

Ejemplares similares

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
por: Lim, Jamie K., et al.
Publicado: (2016)

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire
por: Bolivar, Derek, et al.
Publicado: (2023)

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City()
por: Morgan, Jake R., et al.
Publicado: (2022)

Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
por: Sun, Tianyu, et al.
Publicado: (2022)

Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study
por: Teeter, Benjamin S., et al.
Publicado: (2021)

Examining nonprescription syringe sales in Massachusetts and Rhode Island community pharmacies
por: Green, Traci C., et al.
Publicado: (2021)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies
por: Qiu Hua Chen, Autumn
Publicado: (2022)

If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study
por: Slocum, Susannah, et al.
Publicado: (2022)

The status of naloxone in community pharmacies across Canada
por: So, Randy, et al.
Publicado: (2020)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
por: Dwyer, Kristin, et al.
Publicado: (2015)

Naloxone availability in independent community pharmacies in Georgia, 2019
por: Gilbert, Lauren, et al.
Publicado: (2021)

Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
por: Kerensky, Todd, et al.
Publicado: (2017)

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
por: Walley, Alexander Y, et al.
Publicado: (2013)

Organizational Readiness to Implement Community Pharmacy-Based Opioid Counseling and Naloxone Services: A Scoping Review of Current Practice Models and Opportunities
por: Hohmann, Lindsey, et al.
Publicado: (2023)

Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
por: Nolen, Shayla, et al.
Publicado: (2023)

Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
por: Nolen, Shayla, et al.
Publicado: (2023)

Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose
por: Merlin, Mark A, et al.
Publicado: (2015)

Evaluation of buprenorphine/naloxone dose and use of sedating supportive medication on treatment outcomes in veterans with opioid use disorder
por: Kapuganti, Amber, et al.
Publicado: (2018)

Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013)

Rx for Addiction and Medication Safety (RAMS-PEER): Evaluation of an Education and Peer Program on Opioid Misuse
por: Sun, Tianyu, et al.
Publicado: (2020)

Pharmacy Students’ Perceptions and Stigma Surrounding Naloxone Use in Patients with Opioid Use Disorder: A Mixed Methods Evaluation
por: Cernasev, Alina, et al.
Publicado: (2020)

Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
por: Guadamuz, Jenny S., et al.
Publicado: (2019)

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
por: Ellerbroek, Hannah, et al.
Publicado: (2022)

Naloxone urban legends and the opioid crisis: what is the role of public health?
por: Crabtree, Alexis, et al.
Publicado: (2019)

Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey
por: Hohmann, Lindsey A., et al.
Publicado: (2022)

Safety of Naloxone in Opioid-Naïve Methadone Intoxicated Patients; a Case Series Study
por: Shakeri, Seyed Hamid Reza, et al.
Publicado: (2020)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
por: Metrebian, Nicola, et al.
Publicado: (2023)

Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study
por: Doe-Simkins, Maya, et al.
Publicado: (2014)

Naloxone interventions in opioid overdoses: a systematic review protocol
por: Shaw, Lindsay Victoria, et al.
Publicado: (2019)

From controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
por: Tourunen, Jouni, et al.
Publicado: (2010)

Considering the Potential Benefits of Over-the-Counter Naloxone
por: Evoy, Kirk E, et al.
Publicado: (2021)

Missed Opportunities for HIV Screening in Pharmacies and Retail Clinics
por: Dugdale, Caitlin, et al.
Publicado: (2014)

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016
por: Meyerson, B.E., et al.
Publicado: (2018)

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
por: Kunøe, Nikolaj, et al.
Publicado: (2016)

Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
por: Enteen, Lauren, et al.
Publicado: (2010)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1v2u0400u6mailb17bv0kp1868